Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections.

Jamot S, Raghunathan V, Patel K, Kelly CR, Lim SH.

Infect Control Hosp Epidemiol. 2018 Mar;39(3):302-306. doi: 10.1017/ice.2017.314. Epub 2018 Jan 24.

PMID:
29363436
2.

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP.

Ann Neurol. 2018 Jan;83(1):166-177. doi: 10.1002/ana.25131.

PMID:
29293273
3.

Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.

Kelly CR, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Rabinowitz A, Carrié D, Pompili V, Bouchard A, Saito S, Allocco DJ, Dawkins KD, Stone GW.

JACC Cardiovasc Interv. 2017 Dec 11;10(23):2392-2400. doi: 10.1016/j.jcin.2017.06.070.

4.

Fecal Transplant in Inflammatory Bowel Disease.

Browne AS, Kelly CR.

Gastroenterol Clin North Am. 2017 Dec;46(4):825-837. doi: 10.1016/j.gtc.2017.08.005. Epub 2017 Oct 3. Review.

PMID:
29173524
5.

Hair Growth in Two Alopecia Patients after Fecal Microbiota Transplant.

Rebello D, Wang E, Yen E, Lio PA, Kelly CR.

ACG Case Rep J. 2017 Sep 13;4:e107. doi: 10.14309/crj.2017.107. eCollection 2017.

6.

FMT in IBD: What Have We Learned?

Kelly CR, Allegretti JR.

Dig Dis Sci. 2017 Oct;62(10):2618-2620. doi: 10.1007/s10620-017-4713-9. No abstract available.

PMID:
28840580
7.

The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection.

Allegretti JR, Kassam Z, Osman M, Budree S, Fischer M, Kelly CR.

Gastrointest Endosc. 2018 Jan;87(1):18-29. doi: 10.1016/j.gie.2017.05.036. Epub 2017 Jun 3. Review. No abstract available.

PMID:
28583769
8.

An Updated Protocol for Evaluating Chest Pain and Managing Acute Coronary Syndromes.

Kelly CR, Kirtane AJ, Stant J, Stone GW, Minutello RM, Wong SC, Manuzon H, Gerow-Smith R, Kelley N, Rabbani LE.

Crit Pathw Cardiol. 2017 Mar;16(1):7-14. doi: 10.1097/HPC.0000000000000098. Review.

9.

The AGA's Fecal Microbiota Transplantation National Registry: An Important Step Toward Understanding Risks and Benefits of Microbiota Therapeutics.

Kelly CR, Kim AM, Laine L, Wu GD.

Gastroenterology. 2017 Mar;152(4):681-684. doi: 10.1053/j.gastro.2017.01.028. Epub 2017 Jan 29. No abstract available.

PMID:
28143773
10.

A Retrospective Cross-sectional Analysis of Health Education Disparities in Patients With Diabetes Using Data From the National Ambulatory Medical Care Survey.

Branoff JD, Jiroutek MR, Kelly CR, Huma S, Sutton BS.

Diabetes Educ. 2017 Feb;43(1):125-134. doi: 10.1177/0145721716685408.

PMID:
28118125
11.

Analysis of gut microbiota - An ever changing landscape.

Sadowsky MJ, Staley C, Heiner C, Hall R, Kelly CR, Brandt L, Khoruts A.

Gut Microbes. 2017 May 4;8(3):268-275. doi: 10.1080/19490976.2016.1277313. Epub 2017 Jan 4.

12.

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.

Staley C, Kelly CR, Brandt LJ, Khoruts A, Sadowsky MJ.

MBio. 2016 Dec 20;7(6). pii: e01965-16. doi: 10.1128/mBio.01965-16.

13.

Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.

Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A, Reinert SE, Machan JT, Brandt LJ.

Ann Intern Med. 2016 Nov 1;165(9):609-616. doi: 10.7326/M16-0271. Epub 2016 Aug 23.

14.

Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.

Fischer M, Kao D, Mehta SR, Martin T, Dimitry J, Keshteli AH, Cook GK, Phelps E, Sipe BW, Xu H, Kelly CR.

Am J Gastroenterol. 2016 Jul;111(7):1024-31. doi: 10.1038/ajg.2016.180. Epub 2016 May 17.

PMID:
27185076
15.

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.

Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR, Lombardo MJ, Vulic M, Ohsumi T, Winkler J, Pindar C, McGovern BH, Pomerantz RJ, Aunins JG, Cook DN, Hohmann EL.

J Infect Dis. 2016 Jul 15;214(2):173-81. doi: 10.1093/infdis/jiv766. Epub 2016 Feb 8.

PMID:
26908752
16.

A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection.

Jackson M, Olefson S, Machan JT, Kelly CR.

J Clin Gastroenterol. 2016 Oct;50(9):742-6. doi: 10.1097/MCG.0000000000000447.

17.

Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a Selective 5-HT2 Receptor Agonist.

May JA, Sharif NA, McLaughlin MA, Chen HH, Severns BS, Kelly CR, Holt WF, Young R, Glennon RA, Hellberg MR, Dean TR.

J Med Chem. 2015 Nov 25;58(22):8818-33. doi: 10.1021/acs.jmedchem.5b00857. Epub 2015 Nov 9.

PMID:
26551970
18.

Noninvasive Positive-Pressure Ventilation.

Kelly CR, Higgins AR, Chandra S.

N Engl J Med. 2015 Sep 24;373(13):1279. doi: 10.1056/NEJMc1508384. No abstract available.

19.

Racial Differences in Clostridium difficile Infection Rates Are Attributable to Disparities in Health Care Access.

Mao EJ, Kelly CR, Machan JT.

Antimicrob Agents Chemother. 2015 Oct;59(10):6283-7. doi: 10.1128/AAC.00795-15. Epub 2015 Jul 27.

20.

Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.

Aroniadis OC, Brandt LJ, Greenberg A, Borody T, Kelly CR, Mellow M, Surawicz C, Cagle L, Neshatian L, Stollman N, Giovanelli A, Ray A, Smith R.

J Clin Gastroenterol. 2016 May-Jun;50(5):398-402. doi: 10.1097/MCG.0000000000000374.

PMID:
26125460
21.

Videos in clinical medicine. Noninvasive positive-pressure ventilation.

Kelly CR, Higgins AR, Chandra S.

N Engl J Med. 2015 Jun 4;372(23):e30. doi: 10.1056/NEJMvcm1313336. No abstract available.

PMID:
26039621
22.

Weight gain after fecal microbiota transplantation.

Alang N, Kelly CR.

Open Forum Infect Dis. 2015 Feb 4;2(1):ofv004. doi: 10.1093/ofid/ofv004. eCollection 2015 Jan.

23.

Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet.

Grinspan AM, Kelly CR.

Gastroenterology. 2015 Jul;149(1):15-8. doi: 10.1053/j.gastro.2015.05.030. Epub 2015 May 27. No abstract available.

PMID:
26021232
24.

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G.

Gastroenterology. 2015 Jul;149(1):223-37. doi: 10.1053/j.gastro.2015.05.008. Epub 2015 May 15. Review.

25.

Editorial: a simple faecal preparation protocol for faecal microbiota transplantation.

Kelly CR.

Aliment Pharmacol Ther. 2015 Feb;41(3):320. doi: 10.1111/apt.13039. No abstract available.

26.

Clearing the air on the "smoker's paradox".

Kirtane AJ, Kelly CR.

J Am Coll Cardiol. 2015 Mar 24;65(11):1116-8. doi: 10.1016/j.jacc.2015.01.012. No abstract available.

27.

Can physicians identify inappropriate nuclear stress tests? An examination of inter-rater reliability for the 2009 appropriate use criteria for radionuclide imaging.

Ye S, Rabbani LE, Kelly CR, Kelly MR, Lewis M, Paz Y, Peck CL, Rao S, Bokhari S, Weiner SD, Einstein AJ.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):23-9. doi: 10.1161/CIRCOUTCOMES.114.001067. Epub 2015 Jan 6.

28.

Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study).

Kelly CR, Weisz G, Maehara A, Mintz GS, Mehran R, Lansky AJ, Parise H, de Bruyne B, Serruys PW, Stone GW.

Am J Cardiol. 2014 Aug 1;114(3):376-83. doi: 10.1016/j.amjcard.2014.04.048. Epub 2014 May 16.

PMID:
24931291
29.

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, Aroniadis O, Barto A, Borody T, Giovanelli A, Gordon S, Gluck M, Hohmann EL, Kao D, Kao JY, McQuillen DP, Mellow M, Rank KM, Rao K, Ray A, Schwartz MA, Singh N, Stollman N, Suskind DL, Vindigni SM, Youngster I, Brandt L.

Am J Gastroenterol. 2014 Jul;109(7):1065-71. doi: 10.1038/ajg.2014.133. Epub 2014 Jun 3.

30.

Human non-pigmented ciliary epithelium bradykinin B2-receptors: receptor localization, pharmacological characterization of intracellular Ca(2+) mobilization, and prostaglandin secretion.

Sharif NA, Wang Y, Katoli P, Xu S, Kelly CR, Li L.

Curr Eye Res. 2014 Apr;39(4):378-89. doi: 10.3109/02713683.2013.816324. Epub 2013 Jul 25.

PMID:
24624903
31.

Videos in clinical medicine. Pulmonary-artery catheterization.

Kelly CR, Rabbani LE.

N Engl J Med. 2013 Dec 19;369(25):e35. doi: 10.1056/NEJMvcm1212416. Review. No abstract available.

PMID:
24350972
32.

Trabecular meshwork bradykinin receptors: mRNA levels, immunohistochemical visualization, signaling processes pharmacology, and linkage to IOP reduction.

Sharif NA, Katoli P, Kelly CR, Li L, Xu S, Wang Y, Klekar L, Earnest D, Yacoub S, Hamilton G, Jacobson N, Shepard AR, Ellis D.

J Ocul Pharmacol Ther. 2014 Feb;30(1):21-34. doi: 10.1089/jop.2013.0105. Epub 2013 Nov 16.

PMID:
24236827
33.

Technique for office-based, ultrasonography-guided percutaneous biopsy of renal cortical neoplasms using a novel transducer for facilitated ultrasound targeting.

Menhadji AD, Nguyen V, Okhunov Z, Bucur P, Chu WH, Cho J, Billingsley J, Morrison D, Kelly CR, Landman J.

BJU Int. 2016 Jun;117(6):948-53. doi: 10.1111/bju.12489. Epub 2016 Apr 24.

34.

Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies.

Kelly CR, Kunde SS, Khoruts A.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):283-8. doi: 10.1016/j.cgh.2013.09.060. Epub 2013 Oct 6.

35.

Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B₂ receptors in ciliary muscle.

Sharif NA, Xu S, Li L, Katoli P, Kelly CR, Wang Y, Cao S, Patil R, Husain S, Klekar L, Scott D.

Mol Vis. 2013 Jun 15;19:1356-70. Print 2013.

36.

Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.

De Leon LM, Watson JB, Kelly CR.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1036-8. doi: 10.1016/j.cgh.2013.04.045. Epub 2013 May 10.

PMID:
23669309
37.

Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.

Kelly CR, de Leon L, Jasutkar N.

J Clin Gastroenterol. 2012 Feb;46(2):145-9. doi: 10.1097/MCG.0b013e318234570b.

PMID:
22157239
38.

Percutaneous renal surgery: use of flexible nephroscopy and treatment of infundibular stenoses.

Walsh RM, Kelly CR, Gupta M.

J Endourol. 2009 Oct;23(10):1679-85. doi: 10.1089/end.2009.0229.

PMID:
19630499
39.

Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.

Sharif NA, McLaughlin MA, Kelly CR, Katoli P, Drace C, Husain S, Crosson C, Toris C, Zhan GL, Camras C.

Exp Eye Res. 2009 Mar;88(3):386-97. doi: 10.1016/j.exer.2008.10.003. Epub 2008 Nov 1.

PMID:
18992242
40.

Clinical evaluation of efficacy of novel optically activated digital endoscope protection system against laser energy damage.

Xavier K, Hruby GW, Kelly CR, Landman J, Gupta M.

Urology. 2009 Jan;73(1):37-40. doi: 10.1016/j.urology.2008.07.041. Epub 2008 Oct 9.

PMID:
18848346
41.

High definition in minimally invasive surgery: a review of methods for recording, editing, and distributing video.

Kelly CR, Hogle NJ, Landman J, Fowler DL.

Surg Innov. 2008 Sep;15(3):188-93. doi: 10.1177/1553350608322102.

PMID:
18757378
42.

Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine].

May JA, Sharif NA, Chen HH, Liao JC, Kelly CR, Glennon RA, Young R, Li JX, Rice KC, France CP.

Pharmacol Biochem Behav. 2009 Jan;91(3):307-14. doi: 10.1016/j.pbb.2008.07.015. Epub 2008 Jul 30.

43.
44.

AL-34662: a potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist.

Sharif NA, McLaughlin MA, Kelly CR.

J Ocul Pharmacol Ther. 2007 Feb;23(1):1-13.

PMID:
17341144
45.

Serotonin-2 (5-HT2) receptor-mediated signal transduction in human ciliary muscle cells: role in ocular hypotension.

Sharif NA, Kelly CR, Crider JY, Davis TL.

J Ocul Pharmacol Ther. 2006 Dec;22(6):389-401.

PMID:
17238805
46.

Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.

Sharif NA, McLaughlin MA, Kelly CR, Xu S, Crider JY, Williams GW, Parker JL.

J Ocul Pharmacol Ther. 2006 Oct;22(5):291-309.

PMID:
17076623
47.

Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction.

Sharif NA, Kelly CR, McLaughlin M.

Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4001-10.

PMID:
16936116
48.

Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.

Kelly CR, Sharif NA.

J Pharmacol Exp Ther. 2006 Jun;317(3):1254-61. Epub 2006 Mar 3.

49.
50.

Supplemental Content

Loading ...
Support Center